arrow
Y

Youyi Fong

Fred Hutchinson Cancer Center
H指数:39
被引数:8,816

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct T cell correlates of COVID-19 risk before and after a second booster in previously SARS-CoV-2 infected versus naïve COVAIL trial participants

先前感染SARS-CoV-2与未感染的COVAIL试验参与者在二次加强针前后COVID-19风险的T细胞相关性差异

2026-10-060
OAAI
Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

NVX-CoV2373重组蛋白疫苗PREVENT-19疗效试验中抗体标志物作为严重COVID-19风险免疫相关指标的分析

2025-10-010
PRE
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial

SARS-CoV-2变异株抗体反应的免疫相关性分析:ENSEMBLE疫苗有效性试验

2025-09-290
OAAI
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320

勘误:‘在南部非洲出生时被指定为女性的人群中评估的镶嵌HIV-1疫苗方案免疫原性试验的免疫相关性分析:一项两阶段病例对照研究’。EBioMedicine 2024;108: 105320

2025-08-230
PREAI
HVTN 123: A Phase 1, Randomized Trial Comparing Safety and Immunogenicity of CH505TF gp120 Produced by Stably and Transiently Transfected Cell Lines
2024-12-130
PRE
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people female sex at birth: a case-control study
2024-10-010
PRE
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
2024-09-261
PRE
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 Trial
2023-09-297
OAAI
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
2023-06-1718
OAAI
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial
2023-04-1913
OAAI
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial (vol 14, 331, 2023)
2023-03-222
OAAI
Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine
2023-03-1121
OAAI
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial
2023-01-1949
OAAI
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape

触手可及的呼吸道合胞病毒预防: 疫苗和单克隆抗体的前景

2023-01-01219
OAAI